Dr. Danforth Miller is a hypothesis-driven engineer, scientist, and inventor who brings broad experience in leveraging pharmaceutics, materials science, engineering, and computational modeling to drive effective development of drug products.
As a subject matter expert on multiple inhaled drug product approvals, Miller holds specific expertise in the formulation and physical characterization of small molecules and proteins to prevent and solve problems in applied research and product development environments. He has led multi-disciplinary teams that have conducted early-phase preclinical and clinical development over nearly 25 years at both startups and large pharmaceutical companies, including Inhale Therapeutic Systems (Nektar Therapeutics), Novartis, and Respira Therapeutics. As an author of more than 30 scientific articles and nine issued patents, Miller has worked to advance particle engineering technologies for pulmonary delivery of dry powder aerosols of small molecules and proteins. He is a member of the Editorial Advisory Board at the Journal of Pharmaceutical Sciences and holds a B.S. in Chemical Engineering from the University of Colorado Boulder, as well as a Ph.D. in Chemical Engineering from the University of Wisconsin-Madison.